[VIRTUAL] Synergistic effects of ACT-01 with dimethyl-fumarate or fingolimod for combination therapy in the EAE animal model of MS (ECTRIMS 2021) - Sep 23, 2021 - Abstract #P713; Pres time: Oct 14, 2021; 12:00 PM - 09:00 PM; Location: ePoster Library; "ACT-01 in combination with fingolimod or DMF shows synergistic clinical efficacy in the EAE animal model of MS." Combination therapy • Preclinical • CNS Disorders • Immune Modulation • Immunology • Infectious Disease • Inflammation • Multiple Sclerosis • Pulmonary Disease • Respiratory Diseases • Tuberculosis • GSK3B • NDRG1
|
|
Prof. Pablo Villoslada; G. Vila
|